Back to Search
Start Over
No needle mesotherapy device in treatment of corticosteroid induced striae in systemic lupus erythematosus patients
- Source :
- Benha Medical Journal.
- Publication Year :
- 2021
- Publisher :
- Egypts Presidential Specialized Council for Education and Scientific Research, 2021.
-
Abstract
- Introduction: Mesostyle is a needle free mesotheraputic device that is able to insert analytical pure active substance to the deep layers of skin within cell levels using the most modern electroporation procedure. Objectives: this study aimed to assess electroporation "as a method of transdermal administration of medications" in treatment of corticosteroid induced striae in systemic lupus erythematosus patients. Methods: Twenty female Systemic lupus erythematous (SLE) patients suffering from corticosteroid induced striae in different body parts, were included in this study. Patients were subjected to full history taking, complete clinical examination, and assessment of disease activity using systemic lupus erythematosus disease activity index (SLEDAI) score. Each patient received treatment in the form of six weekly successive cessions using electroporation device "Mesostyle" and photos were obtained after each cession. Results: We found marked improvement of striae appearance with noticeable patients’ satisfaction without any adverse effects. Conclusion: This study supports the role of electroporation which is safe, tolerable, non-invasive, and effective method for transdermal administration of medications.
- Subjects :
- medicine.medical_specialty
medicine.diagnostic_test
business.industry
medicine.drug_class
Systemic lupus
Electroporation
Physical examination
Dermatology
Mesotherapy
General Earth and Planetary Sciences
Medicine
Corticosteroid
Medical history
skin and connective tissue diseases
business
Adverse effect
General Environmental Science
Transdermal
Subjects
Details
- ISSN :
- 23570016
- Database :
- OpenAIRE
- Journal :
- Benha Medical Journal
- Accession number :
- edsair.doi...........b74b76912e97b362c43c0c5dd102b44a